Esther Ellen Freeman, MD, PhD: How COVID-19 Is Affecting Skin Differently in 2023
Symptoms including vestibular rashes and COVID toes have become less synonymous with SARS-CoV-2 infection. Why is that?
Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion
As the pandemic passes its third year, one dermatologist foresees their field's own pursuit of specialty-specific vaccination guidelines.
Berdazimer Gel Provides Complete Molluscum Clearance in 30% of Patients in 12 Weeks
Pediatric dermatologist Mercedes Gonzalez, MD, discusses the new phase 3 B-SIMPLE data supporting berdazimer gel as the first potential molluscum treatment.
Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
The Icahn investigator reviews new data suggesting ethnicity-based differences in molecular phenotype of atopic dermatitis, which may better inform treatment strategies for different populations.
John Harris, MD, PhD: Advancing Vitiligo Care After Ruxolitinib Cream
After last year's historic approval, investigators want to learn more about their available drug regimens, as well as pediatric eligibility.
Megan Noe, MD, MPH: Navigating Vaccines, COVID-19 Boosters with Dermatology Patients
Amid the introduction of immunosuppressant therapies and the ongoing pandemic, dermatologists find themselves guiding new decisions for patient treatment around vaccinations.
John Harris, MD, PhD: Year 1 of Ruxolitinib Cream for Vitiligo
The UMass Chan chair of dermatology recaps a historic year of development for the chronic disease, including the progression of even newer treatment options.
Caitlin Treuting: Medical Photography Grows in Pediatric Dermatology
Beyond the obvious benefits, the practice of remote and in-clinic photography is altering treatment capabilities.
Alberto Pappo, MD: Why Pediatric Melanoma Diagnosis Is In Flux
The St. Jude oncologist discusses the 30-year development of pediatric melanoma interpretation.
Jan Wehkamp, MD, PhD: Expanding the Studies of Ustekinumab for IBD
Recent data during ECCO 23 show ustekinumab results in higher rates of clinical remission and clinical response in patients with inflammatory bowel disease.
Marius Hoeper, MD: Insight into STELLAR Trial Investigating Sotatercept for PAH
At ACC 2023, Hoeper provides insight into the key efficacy findings of STELLAR and delves into the safety concerns and generalizability of sotatercept for PAH.
Maria T. Abreu, MD: Promising Initial Data on Guselkumab From ECCO 2023
Much of the recent focus on drug development in IBD has centered on the IL-23 pathway.
Planning Lung Cancer Screening, Surgery Between Clinicians and Patients
David Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.
Manpreet Singh, MD: The Different Subtypes of ADHD and Mood Disorders
The connection between different ADHD subtypes and mood disorders has not been fully explored.
Manpreet K. Singh, MD: The Challenge of Treating ADHD With Comorbidities
Singh presented during the recent APSARD conference. onthe topic of ADHD and bipolar disorder.
Laura Wingate: Improving All Aspects of Care for IBD Patients
The FDA has approved several biologics in recent years for the treatment of patients with inflammatory bowel disease.
Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis
Falloon said IBD-associated peripheral arthritis is common, but not well understood.
Kendall Beck, MD: Promising New Tofacitinib Data From the Crohn's and Colitis Congress
Dose de-escalation of tofacitinib resulted in less hospitalizations for patients with ulcerative colitis.
Laura E. Raffals, MD: Sifting Through All the Drug Choices for IBD
The potential for personalized medicine in inflammatory bowel disease might. be realized in the next few years.
Adopting Greater CPR Strategies After Damar Hamlin
Michael J. Ackerman, MD, PhD, discusses the simplicity and availability of education around CPR and defibrillator use, and the role of clinicians in raising public health preparedness.
Damar Hamlin and the Commonality of Cardiac Arrest Emergencies
A Mayo Clinic cardiologist discusses the national variability in CPR and AED access, and the actions that saved Hamlin's life during Monday Night Football.
A Reflection on the Limitation of Reproductive Health Rights in 2022
A maternal-fetal medicine physician discusses plans for improvements in 2023.
Daniel W. Coyne, MD: The Need for New CKD Treatments
With the population aging, there is a need for new treatments in nephrology.
The Benign Hematology Patient Journey
Harold Bays, MD: Considering the Future of Anti-Obesity Medications
A continued discussion with Dr. Bays on anti-obesity therapies down the line and where they might be in the near future.
Harold Bays, MD: Transforming Obesity Management with Highly Effective Therapies
Anti-obesity medications have the potential for significant weight reduction, but the development of newer agents may lead to an even greater change in obesity care.
Why Many Smokers Fail to Quit on Their First Attempt
American Lung Association's Jennifer Folkenroth discusses the issues with "cold turkey," and what every habitual smoker should look for in a cessation plan.
Why Health Care Was Unprepared for the 2022 RSV Surge
A pediatric emergency medicine physician discusses the epidemic factors that still perturb experts, and the status of vaccination and treatment strategies.
2022: The Year of JAK Inhibitors
Brett King, MD, PhD, reviews how the drug class has altered the state of chronic skin disease management in this year alone.
Brett King, MD, PhD: Following Up the Ruxolitinib Cream Approval for Vitiligo
Why patience is key following the major FDA decision earlier this year.
